Medicines Formulary

Medicines A–Z

C

Drug name	NICE TAs	Comments
C1 Esterase Inhibitor (Cinryze®, Berinert®)		NHS England commissioned. Hospital only.
Cabazitaxel infusion	TA391 - Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel TA255 - Cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen
Cabergoline tablets
Cabozantinib		TA463 - Cabozantinib for previously treated advanced renal cell carcinoma TA516 - Cabozantinib for treating medullary thyroid cancer TA542 - Cabozantinib for untreated advanced renal cell carcinoma TA849 - Cabozantinib for previously treated advanced hepatocellular carcinoma
Cacit D3 effervescent granules
Cade oil 12% w/w and salicylic acid 6% w/w in emulsifying ointment		Unlicensed special
Caffeine		Hospital only
Calamine aqueous cream
Calamine lotion
Calcipotriol 50 microgram/g ointment

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.